Investing News Network on MSN
DCVC, NVIDIA back Proxima’s US$80 million bet on AI drug discovery
Artificial intelligence (AI) biotech startup Proxima has raised US$80 million in seed funding to accelerate the development ...
PRISM BioLab, Co. Ltd. ("PRISM") and Talus Bioscience, Inc. ("Talus Bio") announced today that they entered into a collaboration to discover novel Inhibitors of transcription factor (TF) and ...
Pharmaceutical and biotech companies on the hunt for new drugs run tests along the way to see how proteins interact. Analyzing protein-protein interaction can reveal how cells communicate, the way ...
The rapid outbreak of severe acute respiratory syndrome‐coronavirus 2 (SARS‐CoV‐2), a novel coronavirus, caused the ongoing coronavirus disease 2019 (COVID-19). Among all the known coronaviruses, SARS ...
Talus Bioscience, Inc. ("Talus Bio"), an AI-enabled regulome therapeutics company, today announced a strategic collaboration with PRISM BioLab Co., Ltd. ("PRISM") to accelerate the discovery and ...
In this Interview, NewsMedical speaks with Amy Landreman about NanoBRET® Technology and its role in cellular target engagement. Could you start by explaining the significance of understanding cellular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback